Navigation Links
Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease
Date:11/12/2007

hold ROP, and treatment-requiring ROP.

Shortly after the physician's examination, a trained nurse captured retinal images of the same child using a wide-angle camera. A period of four to twelve months was allowed to elapse before images were shown to the same doctor who performed ophthalmoscopy, in order to minimize any chance that the examiner could remember details.

In 86 percent of the eyes, there was complete agreement between the diagnoses made by ophthalmoscopy and telemedicine. Among eyes where there was disagreement between the examination modalities, 12 cases involved clinically- significant discrepancies regarding presence of zone I disease or plus disease. Dr. Chiang suggests that telemedicine diagnosis may be more accurate in these cases, because images can be compared directly with standard photographic definitions of zone I or plus disease.

"Telemedicine exam may be more reproducible than if you see an infant's retina only briefly during ophthalmoscopy," he says. "There is a rationale that image-based examination may be better because findings are documented photographically. In many other ophthalmic diseases, definitions are based on standard images, so this has implications for the way we might deliver the best care to patients in the future."

About the American Academy of Ophthalmology

The American Academy of Ophthalmology is the world's largest association of eye physicians and surgeons-Eye M.D.s-with more than 27,000 members worldwide. Eye health care is provided by the three "O's" - opticians, optometrists and ophthalmologists. It is the ophthalmologist, or Eye M.D., who can treat it all: eye diseases and injuries, and perform eye surgery. To find an Eye M.D. in your area, visit the Academy's Web site at http://www.aao.org.


'/>"/>
SOURCE American Academy of Ophthalmology
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email: